A case study of symptomatic urinary tract infection by Shigella sonnei in adult female and a short review on drug-resistant Shigella species
Abstract
Shigella species belong to family Enterobacteriaceae and are causative agents of bacillary dysentery. The whole spectrum of disease caused by Shigella species is called Shigellosis. Shigella has four major subgroups: Shigella dysenteriae, Shigella flexneri, Shigella boydii, and Shigella sonnei. S. sonnei causes the mildest form of bacillary dysentery, and in many cases, it causes only mild diarrhea. It is the most common Shigellosis in developed countries. There are few reported cases of asymptomatic bacteriuria due to S. sonnei both in adults and pediatric patients. Few cases of symptomatic urinary tract infection (UTI) are also reported. In pediatric patients, the common risk factor for UTI is found to be vesicoureteric reflux, especially in females. Recent studies done in various countries show an alarming increase in resistance of Shigella species to commonly used antibiotics such as chloramphenicol, ampicillin, co-trimoxazole, nalidixic acid, fluoroquinolones, macrolides, and cephalosporins. Many outbreaks of Shigellosis by multidrug-resistant (MDR) strains have also been reported. Shigella rarely causes extraintestinal manifestations such as hemolytic uremic syndrome, hyponatremia, reactive arthritis, altered neurologic state, bacteremia, UTI, and vulvovaginitis. UTI is a rare complication of Shigella infection. Here, we report a case of UTI due to S. sonnei in an adult female with diabetes mellitus (DM). We have also done a short review of increasing antibiotic…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.